P62 Parametric Survival Extrapolations of Larotrectinib and Entrectinib for NTRK Fusion Cancers
Dec 1, 2022, 00:00
10.1016/j.jval.2022.09.074
https://www.valueinhealthjournal.com/article/S1098-3015(22)02276-8/fulltext
Title :
P62 Parametric Survival Extrapolations of Larotrectinib and Entrectinib for NTRK Fusion Cancers
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)02276-8&doi=10.1016/j.jval.2022.09.074
First page :
Section Title :
Open access? :
No
Section Order :
10263